Joseph M Unger

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. pmc Patient income level and cancer clinical trial participation
    Joseph M Unger
    SWOG Statistical Center, Fred Hutchinson Cancer Research Center, M3 C102, 1100 Fairview Ave, Seattle, WA 98109, USA
    J Clin Oncol 31:536-42. 2013
  2. ncbi request reprint The person-years saved model and other methodologies for assessing the population impact of cancer-prevention strategies
    Joseph M Unger
    Southwest Oncology Group Statistical Center, Seattle, WA, USA
    Urol Oncol 22:362-8. 2004
  3. ncbi request reprint Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials
    Joseph M Unger
    Southwest Oncology Group Statistical Center, Seattle, WA, USA
    J Clin Oncol 24:141-4. 2006
  4. pmc Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016
    Oliver W Press
    Fred Hutchinson Cancer Research Center, D3 190, 1100 Fairview Ave, Seattle, WA 98109, USA
    J Clin Oncol 31:314-20. 2013
  5. pmc Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomiz
    John A Thompson
    Puget Sound Oncology Consortium, Seattle, WA, USA
    Blood 111:4048-54. 2008
  6. ncbi request reprint Estimated impact of the Prostate Cancer Prevention Trial on population mortality
    Joseph M Unger
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Cancer 103:1375-80. 2005
  7. pmc A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316)
    Sara H Javid
    Department of Surgery, Division of Surgical Oncology, University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195 6410, USA
    Oncologist 17:1180-90. 2012
  8. doi request reprint Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy
    Carol M Moinpour
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    J Clin Oncol 26:112-20. 2008
  9. ncbi request reprint Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lecture
    Joseph M Unger
    Southwest Oncology Group Statistical Center and the Puget Sound Oncology Consortium, Seattle, WA, USA
    J Clin Oncol 21:246s-252s. 2003
  10. pmc Comparison of survival outcomes among cancer patients treated in and out of clinical trials
    Joseph M Unger
    Affiliations of authors SWOG Statistical Center, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA JMU, WEB, ML University of Washington, Department of Health Services Research, Seattle, WA DPM Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA SDR, RE Division of Hematology Oncology, Columbia University, New York, NY DLH
    J Natl Cancer Inst 106:dju002. 2014

Detail Information

Publications12

  1. pmc Patient income level and cancer clinical trial participation
    Joseph M Unger
    SWOG Statistical Center, Fred Hutchinson Cancer Research Center, M3 C102, 1100 Fairview Ave, Seattle, WA 98109, USA
    J Clin Oncol 31:536-42. 2013
    ..Studies have shown an association between socioeconomic status (SES) and quality of oncology care, but less is known about the impact of patient SES on clinical trial participation...
  2. ncbi request reprint The person-years saved model and other methodologies for assessing the population impact of cancer-prevention strategies
    Joseph M Unger
    Southwest Oncology Group Statistical Center, Seattle, WA, USA
    Urol Oncol 22:362-8. 2004
    ..Future models may use other outcomes to assess population impact, including economic, quality-of-life, or various combinations of outcomes...
  3. ncbi request reprint Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials
    Joseph M Unger
    Southwest Oncology Group Statistical Center, Seattle, WA, USA
    J Clin Oncol 24:141-4. 2006
    ..Recognition of this under-representation led to a change in Medicare policy in 2000 to include coverage of routine patient care costs of clinical trials. We conducted an updated analysis of accrual trends...
  4. pmc Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016
    Oliver W Press
    Fred Hutchinson Cancer Research Center, D3 190, 1100 Fairview Ave, Seattle, WA 98109, USA
    J Clin Oncol 31:314-20. 2013
    ....
  5. pmc Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomiz
    John A Thompson
    Puget Sound Oncology Consortium, Seattle, WA, USA
    Blood 111:4048-54. 2008
    ..Posttransplantation IL-2 given at this dose and schedule of administration had no significant effect on PFS or OS. This study is registered at www.clinicaltrials.gov as NCT00002649...
  6. ncbi request reprint Estimated impact of the Prostate Cancer Prevention Trial on population mortality
    Joseph M Unger
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Cancer 103:1375-80. 2005
    ..0% in the PCPT placebo arm vs. 11.9% in the PCPT finasteride arm). Whether the increased Gleason score was valid or was a histologic artifact is under investigation...
  7. pmc A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316)
    Sara H Javid
    Department of Surgery, Division of Surgical Oncology, University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195 6410, USA
    Oncologist 17:1180-90. 2012
    ..Patients older than 65 years are underrepresented in clinical trials. We conducted a prospective study (SWOG S0316) to determine physician- and patient-perceived barriers to breast cancer clinical trial enrollment for older patients...
  8. doi request reprint Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy
    Carol M Moinpour
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    J Clin Oncol 26:112-20. 2008
    ..To compare short- and long-term effects of adjuvant treatment versus observation after surgery on health-related quality of life (HRQL) of prostate cancer patients...
  9. ncbi request reprint Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lecture
    Joseph M Unger
    Southwest Oncology Group Statistical Center and the Puget Sound Oncology Consortium, Seattle, WA, USA
    J Clin Oncol 21:246s-252s. 2003
    ..Meanwhile the prevention of cancer has received less attention...
  10. pmc Comparison of survival outcomes among cancer patients treated in and out of clinical trials
    Joseph M Unger
    Affiliations of authors SWOG Statistical Center, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA JMU, WEB, ML University of Washington, Department of Health Services Research, Seattle, WA DPM Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA SDR, RE Division of Hematology Oncology, Columbia University, New York, NY DLH
    J Natl Cancer Inst 106:dju002. 2014
    ..Clinical trials test the efficacy of a treatment in a select patient population. We examined whether cancer clinical trial patients were similar to nontrial, "real-world" patients with respect to presenting characteristics and survival...
  11. ncbi request reprint Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911
    Oliver W Press
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    J Clin Oncol 24:4143-9. 2006
    ..This study was performed to determine the efficacy of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy followed by tositumomab/iodine I-131 tositumomab...
  12. ncbi request reprint Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model
    Ralph J Tuthill
    Department of Anatomic Pathology, Cleveland Clinic Foundation, OH 44195, USA
    Am J Clin Pathol 118:504-11. 2002
    ..9%) of 166 patients and accurately predicted melanoma-specific mortality in 32 (43%) of 74 patients. The combined or overall accuracy of the Clark model was only 64%...